Director/PDMR Shareholding

RNS Number : 2120V

GlaxoSmithKline PLC

09 January 2013

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline UK and US Performance Share Plans notified the Company and the under-mentioned persons on 8 January 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1363.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $43.98 per ADS following the notional re-investment of the dividend paid to shareholders on 3 January 2013.

	Ordinary Shares	ADSs
Sir Andrew Witty	20,450.937
Dr M M Slaoui		6,122.035
Mr S Dingemans	5,090.784
Mr S M Bicknell	2,087.162
Mr R G Connor	347.518
Mrs D P Connelly		2,901.855
Mr M Dunoyer	2,544.210
Mr S A Hussain	5,481.314
Mr W C Louv		1,786.856
Mr D S Redfern	2,792.816
Ms C Thomas	3,938.648
Mr P C Thomson	787.654
Mr D E Troy		3,380.730
Dr P J T Vallance	4,805.754
Ms E Walmsley	3,195.499
Mr C Weber	695.878
Mrs V A Whyte	373.072

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

9 January 2013

 

END

 

 

RDSDKLFBXFFFBBK